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CLINICAL HISTORY 
A 29 year-old previously healthy female presented with sub-
acute symptoms of weight loss, right upper quadrant pain 
and nausea.  
CBC results: WBC-11.7, Hb- 12.5, Platelet- 286, MCV- 90, 
MCV- 26.8, RDW- 18%.  
Imaging: Ultrasound and MRI of the abdomen were suggestive 
of Budd-Chiari syndrome that was supported by a liver biopsy 
showing features of hepatic outflow obstruction(Figure 1). 
There was no clinical or radiological evidence of 
splenomegaly. The hypercoagulable work-up was negative.  
An underlying Myeloproliferative Neoplasm (MPN) was 
suspected.  
 BONE MARROW FINDINGS 
Complex karyotype, 
bone marrow: 
46,XX,+1,del(1)(p13), 
del(1)(q25),-20 [11] / 
49,idem,+del(1)(p13),
+8,+9[9] 
 
 
FINAL DIAGNOSIS  
• Erythropoietin level- 13.5 mIU/ml (normal)  
• LDH level- 213 IU/L (normal) 
• Iron studies: Serum iron- 39 mcg/dL (low), Iron 
saturation- 8% (low), Iron binding capacity 494 mcg/dL 
(high), Serum ferritin 14 ng/mL (low) 
• Molecular testing (Real time quantitative PCR, peripheral 
blood sample): Positive for JAK-2 V617F mutation; 
Negative for BCR/ABL1 
 
 
 
DISCUSSION 
Is Myeloproliferative Neoplasm with Splanchnic Vein Thrombosis a Distinct Clinical 
Entity? 
Upasana Joneja MD,  Jerald Z. Gong MD, Guldeep Uppal MD 
Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania 
FINAL DIAGNOSIS: MYELOPROLIFERATIVE NEOPLASM, 
POLYCYTHEMIA VERA, CO-EXISTING WITH IRON 
DEFICIENCY, JAK2+ (ASSOCIATED WITH SPLANCHNIC VEIN 
THROMBOSIS) 
• Normocellular bone marrow with reduced myeloid to 
erythroid ratio (1:1) 
• Erythroid lineage with left shifted maturation.  
• Abnormal proliferation and clustering of megakaryocytes 
• The background showed mild diffuse reticulin fibrosis.  
(See Figure 2)  
 
 
OL OW-UP LABORATORY STUDIES 
MPNs comprise of two categories- BCR-ABL1 positive MPN or 
chronic myeloid leukemia and BCR-ABL1 negative MPNs that 
include polycythemia vera, essential thrombocythemia , and 
primary myelofibrosis.  
 
Ten percent of the patients who present with splanchnic 
vein thrombosis (SVT) have an underlying occult or overt 
MPN.  These patient histories are often complicated by iron 
deficiency due to thrombosis and bleeding, which may result 
in normal hemoglobin and/or platelet levels. The 
hypercoagulable state of polycythemia vera is likely a direct 
result of the JAK2 mutation.  As a consequence of mutated 
JAK2 function, there is a generalized hypersensitivity to 
cytokines, with over-expression of pro-coagulant factors and 
adhesion molecules at the vascular wall. Of note, JAK2 exon 
12 and MPL515 mutations are extremely rare in SVT.  
 
A recent meta-analysis has suggested that patients with 
MPNs associated with thrombosis in hepatic veins, and/or 
portal veins are possibly a distinct clinical category than 
patients with MPNs without thrombotic complications 
(Leukemia research 2015;(39):525-529). The clinico-
pathologic features of the former group have been recently 
characterized and include younger age at presentation, 
female predominance and normal peripheral cell counts as 
seen in our patient. As these patients often present with 
normal hemoglobin and/or platelet count due to 
bleeding/thrombosis and iron deficiency, a JAK2 analysis and 
bone marrow biopsy evaluation should always be considered 
a key component of the diagnostic algorithm. Even these 
studies are sometimes not enough to distinguish between 
various MPN entities and a comprehensive approach is 
necessary for reaching a diagnosis. 
 
 
CYTOGENETICS 
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Figure 2. A) Bone marrow core biopsy showing 75% cellularity, 20x B) Clustering of 
megakaryocytes, 200x C) Diffuse increased reticulin fibrosis, 100x D) Myeloid cells 
highlighted with immunostain CD33, 100x E) Glycophorin-A immunostain showing mild 
increase in erythroid lineage ( decreased M: E ratio). 
Figure 1. A) Doppler ultrasound of the liver showing patent right and left hepatic veins, 
with middle hepatic vein outflow obstruction B) Liver, MRI showing hepatomegaly 
(caudate lobe), peripheral fibrosis and edema consistent with subacute Budd-Chiari 
syndrome C) Histology of the liver consistent with outflow obstruction 
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